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Abstract 
Background: Physical inactivity and sedentary behaviour are common among breast cancer survivors. These 
behaviours are associated with an increased risk of comorbidities such as heart disease, diabetes and other 
cancers. Commercially available, wearable activity trackers (WATs) have potential utility as behavioural 
interventions to increase physical activity and reduce sedentary behaviour within this population.  
Purpose: To explore the acceptability and usability of consumer WAT amongst postmenopausal breast cancer 
survivors. 
Methods: Fourteen participants tested two to three randomly assigned trackers from six available models (Fitbit 
One, Jawbone Up 24, Garmin Vivofit 2, Garmin Vivosmart, Garmin Vivoactive and Polar A300). Participants 
wore each device for two weeks, followed by a one week washout period before wearing the next device. Four 
focus groups employing a semi-structured interview guide explored user perceptions and experiences. We used 
a thematic analysis approach to analyse focus group transcripts. 
Results: Five themes emerged from our data: (1) Trackers increased self-awareness and motivation, (2) Breast 
cancer survivors’ confidence and comfort with wearable technology, (3) Preferred and disliked features of 
WAT, (4) Concerns related to the disease and (5) Peer support and doctor monitoring were possible strategies 
for WAT application. 
Conclusions: WATs are perceived as useful and acceptable interventions by postmenopausal breast cancer 
survivors. Effective WAT interventions may benefit from taking advantage of the simple features of the trackers 
paired with other behavioural change techniques, such as specialist counselling, doctor monitoring and peer 
support, along with simple manual instructions.  
 
Keywords: Cancer survivors. Breast cancer. Physical activity. Sedentary behaviour. Wearable technology.  
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Introduction 
Physical activity (PA) after breast cancer diagnosis may ameliorate some of the late-effects of treatment and 
comorbid chronic disease [1]. Guidelines from peak cancer control bodies, such as the American Cancer Society 
[2] and Cancer Council Australia [3]  recommend that cancer survivors should engage in at least 150 minutes 
per week of moderate-to-vigorous physical activity  to improve their treatment outcomes, quality of life and 
overall survival. For many women who have had breast cancer, achieving this goal is challenging, and many fail 
to meet these guidelines [4,5]. In breast cancer, evidence from randomised controlled trials support the efficacy 
of PA interventions in producing short-term behaviour change, but not long-term behaviour maintenance [6]. 
Moreover, many of these interventions utilise in-person delivery for at least some of the intervention sessions, 
which requires personnel and financial resources to sustain. To date, few studies amongst cancer survivors have 
focused on reducing sedentary behaviour (SB), which is also associated with various adverse outcomes [7].  
Wearable activity trackers (WATs) have achieved mass market penetration, with one in five adult consumers in 
the Australia owning one of these devices [8]. WATs have potential for use in scalable behavioural interventions 
to promote PA, as they encourage the use of theory-based self-regulation skills known to be associated with 
behaviour change [9]. One significant advantage of activity trackers is the provision of automated feedback on 
time spent in PA/SB. This feedback can also be integrated with other interactive behaviour change tools (e.g., 
mobile telephone or web-based applications). Interventions incorporating WATs and focusing on PA behaviours 
for senior adults have exhibited promising results [10-12].  
 
To date, several  have examined the usability of consumer WATs, yet most have included only healthy, young 
to middle aged participants [13]. Only a few studies have examined the acceptability of activity trackers 
amongst older adults or those with chronic diseases. Mercer et al. (2016) [11] conducted focus groups to 
examine the usability and usefulness of four different activity trackers in 32 older adults diagnosed with a 
chronic disease (high blood pressure, diabetes, arthritis). Activity trackers were perceived as being both useful 
and acceptable, but it was noted that the lack of comprehensive instruction manuals and technology skills were 
barriers to use. The primary limitation of this study was the short period of testing time of four days which was 
only able to capture very initial impressions about the devices. Another study involving 95 community-dwelling 
older adults (>70 years old) found the device Fitbit One was easy to use, useful and acceptable at both 10 weeks 
and 8 months after enrolling in the study. However, the study evaluated only one popular PA monitor and 
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assessed quantitatively just two main drivers of technology acceptance, namely, perceived usefulness and 
perceived ease-of-use [14]. 
 
Little is known about the feasibility of using WATs in cancer survivor research. Prior to initiating intervention 
studies, it is essential to understand enablers and barriers to adoption of such technology, some of which may be 
specific to different cancer survivor populations. Therefore, the aim of this qualitative study was to explore the 
acceptance and usability of WATs amongst postmenopausal BCS. Our objective was to identify features of 
consumer WATs that would facilitate behavioural interventions focussing on increasing PA and reducing SB of 
this population. 
 
Methods 
The research team began by scoping all WATs that were commercially available in Australia as of May 2015. 
As our longer-term research goal was to utilise wearable technology in a trial setting to increase physical 
activity and reduce sedentary behaviour, we required devices to have two basic features in order to be included 
in this focus group study: a step-count (pedometer) function; and a non-movement notification. Our other 
inclusion criteria were:  having an associated app that was user friendly (assessed by reading user reviews 
posted on websites including www.choice.com.au, www.gizmodo.com.au, and www.cnet.com.au) and 
affordable (less than $500AUD, which excluded the Apple Watch).[15,16] Based on these criteria, we selected 
six devices for testing: Fitbit One, Jawbone Up24, Garmin Vivofit2, Garmin Vivosmart, Garmin Vivoactive and 
Polar A300 (Table 1) . The selected devices had a range of different features to be explored in the focus groups.  
For example, the Fitbit One could be clipped to clothing, whereas others were wrist-worn. The Jawbone Up 24 
could automatically track sleep quality; the Garmin Vivofit 2 used a long life battery rather than needing to be 
charged etc.:   
 
---  Insert Table 1 about here  --- 
 
Participants were recruited predominantly through Register 4, an online community of Australian adults 
interested in participating in health-related research. We also recruited participants via Breacan, an information 
and support service for Victorian women living with breast/gynaecological cancer. Potential participants were 
contacted by a researcher (CL or BML) to complete a screening questionnaire over the telephone to determine 
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eligibility. Post-menopausal women, diagnosed with stage I-III breast cancer, who had completed primary 
treatment at least six months ago, were eligible for recruitment. Other eligibility criteria included residing in 
Victoria, Australia, being able to speak and write fluently in English and having daily access to a handheld 
device or personal computer and Internet. Informed, written consent was obtained for all eligible participants.  
Twenty-one women indicated an interest in the study; after screening, 14 (67%) were deemed eligible and 
provided consent. Participants were randomly assigned two of the six WATs to wear for a minimum of four 
weeks, two weeks per device. A one-week non-wear ‘wash out’ period took place between wearing successive 
trackers. Some participants wore a third device, if time permitted before their scheduled focus group. Two 
researchers (NHN, CL) assisted participants to initialise their tracker and install the app on their smartphone. 
Participants were also briefly guided on how to operate the tracker (push button or swipe), its basic features 
(step counts, sitting alert) and its monitor app (how to sync) and were encouraged to sync the tracker with the 
app daily. At the end of the trial, all participants were invited to pre-scheduled focus groups. Four focus groups 
were conducted between December 2015 and October 2016. Each group included three to four participants. This 
number of focus group sessions was deemed appropriate when saturation point of data was reached, or no 
further relevant information emerged [17]. Each participant was provided with a $50 gift card for their 
participation at the end of their focus group. The study protocol was approved by the Human Research Ethics 
Committee of Cancer Council Victoria (IER-1503). 
 
Participants self-reported their demographic background, PA level and technical skill in a questionnaire before 
their focus group. The focus groups were conducted by two researchers (BML and CL) experienced in the 
cancer and PA context. A semi-structured interview guide was developed including open-ended questions and 
probes. Participants were asked about four topics: (1) awareness of monitoring PA and SB; (2) usefulness of 
devices in changing PA/SB; (3) ease of use and comfort with technology; and (4) feasible strategies to apply 
technology (Table 2). Focus groups were tape-recorded and transcribed verbatim by an independent 
transcriptionist. Data were analysed using a qualitative, thematic analysis approach which attempted to organise 
the data into themes to reflect the participants’ narratives and understand their own experiences without a priori 
hypotheses [18]. Data analysis was performed by two research members [NHN and NH]. Firstly, the researchers 
independently created an initial codebook after reviewing and becoming familiar with the data. All segments of 
the transcripts that had similar underlying meaning were assigned the same code. The two researchers, then, 
refined the concepts of their initial codebook and combined the codes into key themes. As new themes or 
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subthemes emerged, the codebook was revised and the transcripts were re-coded. Following this process, the 
researchers met to discuss the identified themes and subthemes, with discrepancies resolved through consensus. 
Key quotes were identified that were representative of the main themes and sub-themes. NVivo 14.0 (QSR 
International) [19] was used to code and analyse the data. 
---  Insert Table 2 about here  --- 
 
 
Results 
Participant characteristics and study tracker allocation are summarised in Table 3. Five overarching themes 
about the acceptance and preference of WAT among BCS were identified from the focus group data. Selected 
quotes for each theme are in Table 4.  
---  Insert Table 3 about here  --- 
---  Insert Table 4 about here  --- 
 
Theme 1: WATs increased self-awareness and motivation of physical activity  
When asked about the usefulness of WATs, most participants reported that the trackers made them more aware 
of their PA/SB. Interestingly, this self-awareness increased in both active and inactive participants. However, 
participants tended to be aware of their active time rather than the amount of time they spent sitting. Working 
participants, in particular, were less likely to be aware of their sitting time, and had less supportive conditions to 
reduce SB than the non-working group. 
 
The self-awareness of activity data collected by the trackers also acted as a prompt to encourage participants to 
increase their current level of PA. Participants reported feeling inspired and satisfied knowing that they achieved 
the targeted number of steps for a day. They also felt accountable and motivated to put in additional effort when 
they were close to achieving their target. This implies that a clear, achievable goal, represented by the specific 
number of steps, was likely the most significant motivation for participants. 
 
Participants reported that the activity trackers helped them incorporate PA into their daily routines and increased 
“opportunistic” movement, e.g., park the car further away, use stairs instead of lift, etc. Nevertheless, three 
participants reported that they stopped using the trackers, or only used them occasionally after a period of time 
even though they increased their awareness and motivation to do more exercise. 
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Many BCS perceived that they may have higher motivation to use WATs to increase their exercise than women 
without cancer, since BCS knew exercise could help prevent recurrence of cancer and improve general 
wellbeing. However, at the same time, treatment side effects and overall poorer health were attributed as the 
main barriers for BCS becoming active after cancer treatment, which in turn may imply an impediment to the 
WAT use to increase activity. 
 
Theme 2: Confidence and comfort with wearable technology 
12 out of 14 participants  considered themselves as not “tech-savvy” or “technology skilled”, yet most (11 
participants) did not encounter technical difficulties in operating the basic features of the tracker and its 
application (smartphone or web-based). There were, however, two women who found it challenging to set up 
the device, get them to sync or understand how to use the app. These women also felt disinterested and 
demonstrated a lack of readiness to incorporate new technical platforms into their existing practices. In addition, 
many participants reported that they did not use all of the features of the trackers and mostly relied upon the step 
counts. Limited technical abilities could be one potential explanation that hindered the exploration of more 
advanced features, which in turn might sub-optimise the effect of trackers on behavioural change. 
 
---  Insert Table 5 about here  --- 
 
Theme 3: Preferred and disliked features (Table 5) 
i. Preferred features. Step counting was most frequently mentioned by participants as the favoured feature. 
This finding was connected to the above subtheme that participants were more aware of active time than 
sedentary time. In terms of prompts about SB, it appeared that vibration or buzzing was a more effective prompt 
than the coloured bar or beeps featured on some devices with all 9 participants using the Garmin Vivosmart and 
Jawbone Up24 having the buzzing feature agreed with this. Many (12 participants) liked getting real time 
feedback of their behaviour on the device or on the apps, although a few preferred using the web or computer-
based feedback. The aesthetics of the trackers were considered to be crucial in determining preference and 
likelihood to use. Two women reported that they would not wear the tracker going out due to the way they 
looked. Some participants preferred trackers which had a smaller design (e.g., Fitbit One, Garmin Vivoactive, 
Jawbone Up 24) but also said that the small size would make trackers less likely to be noticed or harder to view 
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and operate. The majority of participants liked the WATS that had a larger screen and clear text (Garmins and 
Polar) (10 out of 14 participants) which make the device easier to read than small screen or non-visual display . 
The convenience in operating the WATs was also very important to participants. This was reflected by a certain 
number of comments relating to “easier to see”, “visual screen that always faces you rather than sideways”, 
“always on your wrist like a watch”, or “easier to push the buttons”.  Trackers that were easy to sync or did not 
require frequent charging (e.g., Garmin Vivofit2 has 1-year long battery life) were also viewed positively. Some 
liked the positive reinforcement measures associated with certain trackers (e.g., inspiring emails sent by Fitbit) 
and preferred these over not receiving feedback. 
 
 
ii. Disliked features.  Participants reported several features of WATs which were perceived as unhelpful, or 
made them feel uncomfortable or annoyed. One of these was the auto-goal function which automatically adjusts 
a user’s daily step goal based on their previous activity levels. Participants reported the auto-reduced goals made 
them less motivated compared with the fixed goals on other trackers. Two participants did not like wearing the 
device to bed as they found them uncomfortable. Two women reported the annoyance of the buzzing indicator 
for sedentary time, particularly in circumstances where participants could not alter their behaviour (e.g. while 
driving, seeing movies) or when they were already tired at the end of the day. Due to frustration with the 
buzzing trigger in such circumstances, participants gradually tended to ignore its effect.   
 
A few participants were concerned about the accuracy of the devices, noting that some trackers had not 
accurately measured their activity. Some noted that the trackers appeared to display many more steps than their 
actual steps and didn’t register light intensity PA (e.g., standing, slow walk) as a break from sitting. In addition, 
participants reported that the trackers were improperly validating activities other than walking, such as yoga or 
strength training, which further made participants feel unmotivated because their efforts were not properly 
recognised. 
  
Theme 4: Concerns related to cancer  
Most participants expressed their concerns that treatment side-effects such as tiredness, fatigue and losing 
weight limited their exercise efforts. Lymphedema is one of the most common side-effects after breast cancer 
treatment among those who have had lymph nodes removal surgery or radiation therapy and usually occurs in 
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the arms and hands [20].Two participants expressed their concerns that lymphedema may cause discomfort 
when wearing wrist-worn trackers, although no such side-effects were observed during the trial. Beside 
treatment side-effects, some participants had other chronic comorbidities (e.g., arthritis, obesity) which 
prevented them from exercising. Some women also said their doctors did not provide information or encourage 
them to do exercise after their treatment. These barriers or lack of support may limit the PA as well as intention 
to use trackers to improve their PA. 
 
Some noticeable concerns participants brought up involved the potential adverse effect of these trackers on the 
treatment (radiation therapy), stimulation of cancer tissues and effect on physical health. Two BCS noted their 
concern about the potential adverse effects that WATs could have on their health.  
 
Theme 5: Strategies for application in breast cancer survivors 
Overall, participants’ impressions of wearable activity trackers were positive. Participants generally enjoyed the 
opportunity to wear the trackers, and found them helpful in changing behaviours. People also expressed 
willingness to buy a tracker in future to monitor their PA/SB with the price of AUD 100-150 considered 
acceptable. When asked for their opinion on how to best utilise wearable activity trackers to promote PA among 
BCSs, participants suggested that peer support from other women with breast cancer might assist and 
complement the use of these devices. In addition, they would be comfortable to share their data with, and gain 
encouragement from, women in the same situation. Others thought that friends and social networks (Facebook, 
Twitter) could assist BCSs to increase their activity.  
 
Some participants suggested the need for greater promotion of physical exercise from doctors and oncologists 
for women with breast cancer. It was noted that women were being measured and tested frequently during 
treatment so similar monitoring could be done with PA. One participant suggested her experience of joining an 
exercise competition held by her insurance company to win a fitness band could be a feasible strategy. 
 
Discussion 
Increasing physical activity is an important and well recognised strategy for improving health outcomes 
amongst BCS. WATs are rapidly growing as promising technology to promote such behaviours, in part due to 
their recognizable strengths in boosting motivation, physical ability and their psychological triggering effect 
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[10,21-23]. However, there has been limited evidence about the usability and acceptability of such technology 
amongst cancer survivors. To our knowledge, the present work, though exploratory, is the first in-depth study 
exploring factors associated with wearable technology acceptance and including suggestions of feasible 
strategies to apply such technologies amongst BCS.  
 
We found that the majority of BCS experienced wearing the trackers as comfortable and helpful in motivating 
them to improve their PA levels and reduce SB. In the view of perceived usefulness of the wearable technology, 
BCS showed some similarities as well as significant differences with the general population [11,14,24,25,21]. 
Interestingly, we did not observe any consistent differences in WAT preferences between the active and inactive 
participants. The greatest advantage of wearable trackers is that they help users increase awareness of their 
current activity levels [11]. Previous studies showed that the perceived usefulness of the technology was usually 
evident when a user had a health concern [24]. Our study consolidated that evidence, in that participants 
perceived more awareness and motivation to increase exercise than women without the disease. However, 
participants mostly increased their awareness of the amount of time spent active or number of steps achieved, 
but not the time spent sedentary. Overall, there was little awareness of the importance of SB reduction in this 
BCS group. SBis a particularly important consideration among cancer survivors, as it is adversely associated 
with some mechanisms operative in carcinogenesis [26], and with increased overall cancer mortality regardless 
of moderate-to-vigorous activity levels [27,28]. Future interventions aiming at promoting healthy lifestyles for 
cancer survivors, including BCS, should simultaneously focus on double goals of increasing PA and reducing 
SB using promising technology support such as WATs. 
 
Our study participants shared some of the same barriers to new technology acceptance with the general older 
population such as limited tech-knowledge (self-confidence), lack of readiness to conversion and not being 
interested in new technology [11,14,24]. The provision of additional technical support (possibly delivered face-
to-face or easy-to-understand manual documents) might be beneficial in interventions targeting older adults, to 
allow them to make full use of the devices.  One of the key lessons we learned from this study related to which 
specific features of wearable activity trackers were preferred by our BCS participants. Similar to the general 
older population, BCS liked the most simple features of the trackers: the clear and achievable step-goal display, 
instant feedback, and easy-to-read screen and text display [11]. Charge-free battery life is suggested as 
important feature especially for the older population. BCS also found the buzzing trigger more effective than the 
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visual trigger as a sedentary prompt. Participants suggested that they like to receive frequent positive 
encouragement via emails, SMS or get peer support via social groups (Facebook, Twitter). Most of participants 
expressed comfort and confidence in using the new technology, but frustration also came during the use of some 
features such as the auto-adjusted step goal, the buzzing at inconvenient times, and limited tech-ability to use 
advanced features. We did find some discrepancies in preferred/disliked features of the WATs, which has 
implications for their use in future research trials. It is important to focus test devices with specific populations 
before selecting a WAT to use, however it is unlikely that complete consensus will ever be achieved. Allowing 
users some discretion in which features they utilise is one approach that may enhance adherence. Another 
strategy might be providing users with the option of two WATs that are essentially providing the same 
feedback, but differ in aesthetics and features such as visual display size. 
 
Importantly, there were some specific disease-related barriers to use of the WATs noted. These included chronic 
comorbidities that sometimes made it difficult to wear the trackers, treatment side effects and fear of 
electromagnetic effects. The provision of advice on appropriate strategies to overcome treatment side effects 
may help to promote PA. There has been long-time concerns amongst the public in relation to electromagnetic 
radiation from wearable devices such as cell phone or activity trackers, despite there being little evidence to 
support such arguments [29]. Education materials may need to specifically address these concerns if wearable 
devices are to be incorporated into interventions in this population.  
 
Peer support or involvement of doctors and oncologists in promoting PA were suggested as potentially feasible 
strategies to encourage WAT use among BCS. Peer support and health professionals’ advice have been found 
feasible and effective in delivering behaviour change interventions among cancer survivors [31, 32]. Our BCS 
participants expressed they were encouraged to receive advice on PA and willing to share their exercise 
monitoring progress with their doctors and oncologists. They also felt motivated and encouraged to do exercise 
with women having the same medical conditions with them and using the same activity trackers. Furthermore, 
wearable technology can be connected with social networks, e.g., Facebook or Twitter, to deliver the peer 
support. Thus, there is a viable potential of pursuing these approaches in behavioural interventions applying 
wearable technology. 
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This study has several considerable strengths. We provided participants with the WATs for a period long 
enough (two weeks per device) to give some insight into longer-term use of these devices rather than just the 
initial impressions. In addition, we tested a variety of commercially available devices with different features, 
which helped us gain more perceptions into particular features that are more acceptable and feasible for this 
population. The primary limitation of our study is that participants did not try all the testing devices (six fitness 
bands) and some trackers (the Garmin Vivofit2, Vivosmart and Fitbit) were tested more frequently than others 
(Jawbone,Polar A300 and Garmin Vivoactive) due to some technical issues that occurred during the trial (e.g., 
stop-syncing Jawbone and Polar A300, and broken screen Garmin Vivoactive). Hence, the overgeneralizing 
findings are more applicable for three models Garmin Vivofit2, Vivosmart and Fitbit One. Further, the mean age 
of participants in our study (59 years) is younger than post-menopausal BCS overall. This could have affected 
perceptions, particularly relating to ease of use and comfort with technology. While the data we collected were 
highly informative, more research is needed to better understand the optimal design of interventions using 
wearable technology for breast cancer survivors. It is also worth exploring the factors associated with adherence 
to long-term use of WATs in this group. 
 
Conclusion  
A crucial strength of WATs is in raising breast cancer survivors’ awareness of their PA and SB levels. Our key 
finding is that activity trackers appear to be acceptable to this population and therefore may be a feasible and 
cost effective strategy to use in PA/SB interventions in this group. Effective wearable technology interventions 
may benefit from taking advantage of the simple features of the trackers (e.g., step counts and buzzing) paired 
with other behavioural change techniques, such as specialist counselling, doctor monitoring and peer support. 
Clear and simple instructions guiding installation of apps and use of the device could also be important for 
maximising uptake and maintenance. 
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Table 1. Specific features of wearable activity trackers selected for testing in the study 
Specific features Fitbit 
One 
Jawbone 
Up 24 
Garmin 
Vivofit 2 
Garmin 
Vivosmart 
Garmin 
Vivoactive 
Polar 
A300 
Non-movement 
notification 
visual vibration visual/ 
audio 
visual/ 
vibration 
visual/ 
vibration 
vibration 
Pedometer (steps) 
     
Display steps 
     
Display proportion of steps 
taken and target goal 
  
   
Default or auto goala Default Default Auto Auto Auto Default 
Altimeter (stairs)       
Wearing position Clip-on Wristband Wristband Wristband Wristband Wristband 
Sleep monitor       
Cost (AUD) 123 149 99 199 399 299 
Battery life 14 days 14 days 1 year 7 days 21 days 4 weeks 
Number of participants 
testing the device 
6 1 8 8 3 4 
a Default or auto-goal: “Default” indicates that devices have default step goals of 10,000 steps per day. “Auto 
goal” indicates that devices will create a daily step goal automatically based on user’s previous activity levels, 
i.e, if user achieved only 5000 steps under the goal of 7,500 steps, the step goal will reduce to 6,500 steps on the 
next day to make the goal more achievable.  
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
18 
 
Table 2. Focus group guide 
Topics Questions Elaboration questions 
Awareness of 
monitoring PA/ SB 
When you think of monitoring your 
physical activity/sitting time, what comes 
to mind? 
How does monitoring PA/sitting 
time make you feel? Usefulness of 
monitoring? Were you surprised of 
how much you moved or sat? 
Usefulness of the 
wearable monitor 
When you wore your physical activity 
monitor, how did you feel about wearing 
it? 
Did you change your life routine? 
What are more useful and less useful 
sides of wearing the monitors?  
Ease of use and 
Preference of features 
How easy or difficult did you find using 
the activity monitor? What are your likes or 
dislikes about the activity monitor and/or 
its app? 
If difficult, did you need help from 
others in using this new technology? 
Any suggestions to resolve 
difficulties? Any preference 
features? Any privacy concerns?  
Strategies to apply 
wearable technology in 
future 
Your thoughts about the feasible 
application of wearable technology to 
improve physical activity and reduce 
sedentary behaviour amongst breast cancer 
survivors? 
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Table 3. Participant characteristicsa 
Participant Age Breast cancer 
stage 
Treatment 
receivedb 
Physical 
activity level 
Technology 
skill 
1st tracker 2nd tracker 3rd tracker 
1  57 3 SU+CH+HR Active Intermediate Vivofit2 Vivosmart Polar A300 
2  60 3 SU+CH  Inactive Novice Polar A300 Vivofit2 Vivoactive 
3  62 2 SU+CH+RA+HR Inactive Intermediate Fitbit One Vivosmart Vivofit2 
4 60 3 SU+CH+RA Active Skilled Vivosmart Vivoactive Fitbit One 
5 62 3 SU+CH+RA+HR Inactive Novice Vivosmart Polar A300 N/A 
6 61 3 SU+CH +RA+HR Active Intermediate Fitbit One Vivoactive N/A 
7 62 3 SU+CH Active Novice Vivofit 2 Vivosmart N/A 
8 62 3 SU+CH +RA+HR Inactive Novice Vivofit 2 Polar A300 N/A 
9  51 2 SU+CH Inactive Intermediate Fitbit One Vivosmart N/A 
10 52 2 SU+CH+RA+HR Inactive Intermediate Fitbit One Vivofit 2 N/A 
11 64 2 SU+CH+RA Active Novice Vivofit 2 Fitbit One N/A 
12 57 2 SU+CH Active Intermediate Vivosmart Vivofit 2 N/A 
13 56 2 SU+CH+RA+HR Inactive Intermediate Vivofit 2 Vivosmart N/A 
14 57 2 SU+CH+RA Active Skilled Jawbone Up 24 Vivofit 2 N/A 
a Participants self-reported their current age, cancer stage, treatment received, physical activity level and technology skill 
b SU Surgery, CH Chemotherapy, RA Radiotherapy, HR Hormone therapy 
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Table 4. Participant quotations and related themes 
Theme Participant quotes Participant 
identifier 
Theme 1: Trackers 
increased self-awareness 
and motivation of PA/SB 
I could say before I started I felt that I wasn't doing enough activity, so 
going into it I was keen to see what does my everyday activity measure and I 
was sort of quite surprised at how much I actually did. I walked to the 
station and this [the tracker] said “Oh, it’s 1500 steps” so it did change my 
thinking a bit on that plane.  
P3, FG1, 
Age 62 
 Definitely you didn't realise how long you [have been sitting], I think 
I've been sitting for 15 minutes and it's [actually] an hour, particularly when 
you're working, time just flies past and all of a sudden.... And I also didn't 
realise that you should move as often as they say that you should, but yes 
definitely time goes fast. 
P5, FG2, 
Age 62 
 If you get to say 8,000 [steps] in a day, you're more motivated to do 
those extra 2,000 because you're so close. It's like “Why would I stop now?” 
I might as well keep going. 
P10, FG3, 
Age 52 
 What was good was I realised that if I left the car and went somewhere 
I would get enough steps. It really didn’t matter how far it was if there was 
some purpose, then I would get a lot more steps. And I went to a dog walks, 
went with a friend to walk. I didn’t realise it was quite easy to hit the target 
given that. I had to do that because I wouldn’t have time to run around 
getting steps, so it [the exercise] had to fit in. 
P4, FG1, 
Age 60 
 When I first started wearing it [the tracker] I did quite consciously go 
on some walks and things that I know I would never have before, so I 
thought that was quite good, but it actually wore off after a while. I think 
you need something to encourage you to do it [exercise].  
P2, FG1, 
Age 60 
 I think women with breast cancer would be so much more motivated. I 
mean if you're just trying to lose five kilos, well, maybe you're motivated. 
But if you want to stop cancer from coming back and you can contribute to it 
in some way, to me that was a massive for me to get up and start walking. 
P14, FG4,  
Age 57 
Theme 2: BCS confidence 
and comfort with wearable 
technology 
Once I understood how it worked, it was easy, you know you hit sync 
on this, open the app and little whirly twirly things happened and it spat out 
the findings so 
P5, FG2, 
Age 62 
 I had no trouble using them [the trackers] […]all I had to put in my 
steps, at work we're doing a stepathon, the 10,000 steps, that was easy. You 
go to the calendar and it was easy just to fill in. 
P9, FG3, 
Age 51 
 It [Garmin vivofit] was very simple, I set the steps to come up first as I 
was wearing the watch on the other hand but that changed [my physical 
activity] and it was simple. I didn’t have any issues with the charging. 
P4, FG1, 
Age 60 
 It's not simple, I agree. It took a few days for me to get used to widgets 
and apps and things like that but they are [the instruction] quite limited so 
that took a little bit to set up. 
P4, FG1, 
Age 60 
 I have a little bit of trouble with the Garmin’s getting them to set up, so 
in the end I just gave up. 
P2, FG1, 
Age 60 
 I am a bit old school I don't think the experience [using the tracker] 
would make me necessarily go out and buy one. If I felt I was reasonably 
active doing what I do, in my normal daily activities, I would probably be 
happy with that, but then I tend to ignore technology if I can. 
P7, FG2, 
Age 62 
 Using the app I just feel as if I had very limited [skills] ... and it’s 
probably through my lack of skills... and limited interaction with it. Like, I 
knew how to sync it and look at the stuff and read it and say “That was quite 
interesting” but I didn't do anything else with it [the app]. 
P7, FG2, 
Age 62 
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Theme 3: Preferred and 
disliked features of activity 
trackers 
  
i. Preferred features I just followed the step count. I found the step count encouraged me to 
have to get over my 10,000 steps. […] I think, because that's a number that 
just always sticks in my head. 
P9, FG3, 
Age 51 
 I thought it [the buzzing] was a good, the ones [trackers] that either 
buzzed at you, that I noticed. The first one I had didn’t have any signs so it 
didn’t make any difference but the ones that buzzed at me I consciously 
thought “Yeah, I've been sitting for long time”. 
P1, FG1, 
Age 57 
 I had the Polar first […] I thought it was quite heavy and quite clunky 
but then I had the two Garmins and in the end I decided that was my 
favourite even though it was heavier. I thought it was easier to push the 
buttons and see where you were rather than the others. 
P2, FG1, 
Age 60 
 If I buy one I would buy just for the fact it’s got a bigger screen, easier 
to see, the numbers are facing you rather than sideways. You can actually sit 
there and actually look at it […] without having to swipe through that, you 
can either go into it or ignore it or you can set it up a little more 
personalised. 
P5, FG2, 
Age 62 
ii. Disliked features It was a Garmin, say the goal is 10,000 [steps] and you had a lazy 
morning, it drops down to 8,000 and then 6,000 and […] “No, I still want to 
do my 10,000” […] I would rather have the goal set and if I didn't reach my 
goal, that’s something I am going to have to deal with but with the goal 
changing, I could have sat there and the goal would have just dropped, it 
didn’t seem to be rationale. 
P1, FG1, 
Age 57 
 I looked down, it [the tracker] had a message that said “Move!”. I 
thought, that's a bit cheap because I've been busy all day working and busy 
all day, and now I'm finally sitting down and it wants me to move again. 
P11, FG3, 
Age 64 
 I did [ignored the buzzing], by the end of the six weeks I couldn’t be 
bothered [by the buzzing]. 
P2, FG1, 
Age 60 
 For example strength training, like a pump class, there’s no category 
that says strength training, like sometimes you would use walking [to 
measure strength training], I would get my steps around the gym, which are 
a lot but that [number of steps collected] is kind of nothing. 
P4, FG1, 
Age 60 
Theme 4: Concerns related 
to the disease 
Also, lymphedema, taking the nodes off, I can't have that pressure on 
that side [of the arm] so that's another thing. 
P9, FG3, 
Age 52 
 Because I'm on medication, and I've got the joint issues. So that's 
really, I'm really- not struggling but just it stops me doing, you know 5,000 
I'm all right, if you push me to 6 or 7 [thousand steps], I'm in tears because 
of the joints. 
P13, FG4, 
Age 56 
 The chemo killed my brain. Also, weight loss, because I put on a lot of 
weight with the steroids, etc. as well, which in turn means I don't feel like 
walking or exercising because I feel so tired all the time. 
P8, FG3, 
Age 62 
 I found my breast surgeon and the oncologist didn't say anything about 
exercise. It's really just up to me. My breast surgeon said "Just go back to 
your normal life" is what he said. 
P11, FG3, 
Age 64 
 I don't want something that's electronic on my body because it might 
influence another episode, I don't know, you just don't know.   
P10, FG3, 
Age 52 
 I didn't like wearing it at night. I didn't feel comfortable. I wanted to be 
away from all sort of electrical kinds of things when I sleep. I even have the 
clock radio quite away and I don't sleep near any power points or anything. 
I've had breast cancer a few times, it’s always been caught early but you still 
P11, FG3, 
Age 64 
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think you do what you can to keep away from any kind of an influence you 
think might be affecting you. 
Theme 5: Possible 
strategies for Wearable 
technology application 
I think if you offered it to a group of women who were going through 
treatment, whether it’s their chemo or they had just finished and they were a 
group of women you had just got together and said “Why don’t we all try 
using a device and build up our steps or monitor each other” I think that 
would be really positive. […] I think a group of women like that it could be 
quite encouraging. 
P2, FG1, 
Age 60 
 In this day of social media I have a lot of groups of friends that are 
Fitbit people and they have their own groups and there is a bit of 
competition amongst the friends and not that it’s a “You must do this”, 
“Who made 8,000 today”, “Who made 9,000 today” and they give each 
other badges and pats on the back and so it becomes quite social and that's 
quite important I think. We always say if you train with a friend you're less 
likely to pull out but if you going to say “I am going to do it on my own” 
then it is easier. 
P6, FG2, 
Age 61 
 They [the doctors] haven't said much but I think they should encourage 
people to do more exercise, really, not just go back to your normal life. 
“How much exercise are you doing? Are you able to monitor it?” This is 
what the surgeon could suggest getting one of those Fitbit, find out exactly 
how much you're doing and then exercise is really good so try and do more, 
try and have some goals. I think that should be encouraging people because 
it's good to get encouragement. 
P11, FG3, 
Age 64 
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Table 5. Positive and negative statements about the study activity trackers 
Tracker name Positive statements  Negative statements 
Fitbit One “Fitbit would send you the encouraging emails 
about your progress, that was good” 
“Fitbit was so unobtrusive, it was small, 
could be out of sight and completely 
unaware of” 
Jawbone Up 
24 
“Jawbone vibrates to remind you which is 
good” 
“Sometimes I had no idea why it was 
vibrating. Sometimes while I was walking, 
sometimes it was 10 o’clock at night.” 
Garmin 
Vivofit2 
“You don't have to charge, has a long battery 
in it. I loved that because sometimes when 
you charge them and you forget about them” 
“It [Vivofit2] was clunky pressing the 
button, you had to go through everything 
and if you missed you would have to go 
through. It was a bit annoying.” 
Garmin 
Vivosmart 
“It was light, simple and was quite easy to 
look at the steps and the goals” 
“Vivosmart was a bit annoying having to 
clip it into […] The sleep was interesting 
but of the long-term it kind of didn’t seem 
to tell me anything” 
Garmin 
Vivoactive 
“You would be tapping away and swipe and 
because it had a bigger screen like a picture 
before you.[…] And it had a hell of a lot of 
functionality.” 
“I was critical of the Vivoactive because of 
the chunkiness, it was clunky”. 
Polar A300 “I like the way the Polar gave you points and 
told you how much, half an hour more of 
walking or 3 hours of up time that you needed 
to do to get your points” 
“I didn’t like the Polar at all, because it 
was big and clunky and heavy so I just 
stopped wearing it.” 
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